A, B., SMM, S., AS, A., MA, A., MDG, A., A, R., . . . Zakiullah. (2026). Pharmacogenetics of RAS-affecting AGT and ACE variants and the efficacy of Valsartan/HCTZ therapy. Scientific reports, 16(1), . https://doi.org/10.1038/s41598-026-42902-4
Chicago Style (17th ed.) CitationA, Baig, et al. "Pharmacogenetics of RAS-affecting AGT and ACE Variants and the Efficacy of Valsartan/HCTZ Therapy." Scientific Reports 16, no. 1 (2026). https://doi.org/10.1038/s41598-026-42902-4.
MLA (9th ed.) CitationA, Baig, et al. "Pharmacogenetics of RAS-affecting AGT and ACE Variants and the Efficacy of Valsartan/HCTZ Therapy." Scientific Reports, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41598-026-42902-4.
Warning: These citations may not always be 100% accurate.